Published Paper Details:

A micro-engineered synthetic technology which replicates the makeup and functioning of living tissues is known as an "organ on a chip." Using a small system that blends technology, cell life, and biomaterial technology. A number of experimental examples using various organs, such as skin, gut, heart, liver, or airways upon chips, were successfully constructed. The United States Food and Drug Administration (FDA), which showed faith in this innovation, is working with other groups and businesses who use its contents. The Organ-on-a-Chip algorithm's theories and applications--including the creation of medical designs, drug evaluation, toxicity, pathophysiology studies, effectiveness examination, and virology--are covered by this overview. Considering the challenges posed by the present COVID-19 outbreak, it is projected that merging numerous organs-on-chip components to one body-on-chip system will prove required for detection and treatment. It is projected that demand for manufacturing organ-on-chip systems would increase quickly.